These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 34202190)
21. Serum hyaluronan: a marker of liver fibrosis in patients with chronic liver disease. Tangkijvanich P; Kongtawelert P; Pothacharoen P; Mahachai V; Suwangool P; Poovorawan Y Asian Pac J Allergy Immunol; 2003 Jun; 21(2):115-20. PubMed ID: 14629129 [TBL] [Abstract][Full Text] [Related]
22. Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis. Guéchot J; Serfaty L; Bonnand AM; Chazouillères O; Poupon RE; Poupon R J Hepatol; 2000 Mar; 32(3):447-52. PubMed ID: 10735615 [TBL] [Abstract][Full Text] [Related]
23. Clinical significance of activity of ALT enzyme in patients with hepatitis C virus. Akkaya O; Kiyici M; Yilmaz Y; Ulukaya E; Yerci O World J Gastroenterol; 2007 Nov; 13(41):5481-5. PubMed ID: 17907292 [TBL] [Abstract][Full Text] [Related]
24. Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection. Alberti A; Noventa F; Benvegnù L; Boccato S; Gatta A Ann Intern Med; 2002 Dec; 137(12):961-4. PubMed ID: 12484711 [TBL] [Abstract][Full Text] [Related]
25. Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: a collaborative study between Japan, Egypt, and Uzbekistan. Agha S; Tanaka Y; Saudy N; Kurbanov F; Abo-Zeid M; El-Malky M; Khalaf M; Ohta N; Yoshizawa H; Mizokami M J Med Virol; 2004 Jun; 73(2):216-22. PubMed ID: 15122795 [TBL] [Abstract][Full Text] [Related]
26. APRI test and hyaluronic acid as non-invasive diagnostic tools for post HCV liver fibrosis: Systematic review and meta-analysis. El Serafy MA; Kassem AM; Omar H; Mahfouz MS; El Said El Raziky M Arab J Gastroenterol; 2017 Jun; 18(2):51-57. PubMed ID: 28579340 [TBL] [Abstract][Full Text] [Related]
27. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis. Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611 [TBL] [Abstract][Full Text] [Related]
28. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease. Hartley JL; Brown RM; Tybulewicz A; Hayes P; Wilson DC; Gillett P; McKiernan P J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988 [TBL] [Abstract][Full Text] [Related]
29. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index. Kelleher TB; Mehta SH; Bhaskar R; Sulkowski M; Astemborski J; Thomas DL; Moore RE; Afdhal NH J Hepatol; 2005 Jul; 43(1):78-84. PubMed ID: 15894397 [TBL] [Abstract][Full Text] [Related]
30. Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C. Patel K; Lajoie A; Heaton S; Pianko S; Behling CA; Bylund D; Pockros PJ; Blatt LM; Conrad A; McHutchison JG J Gastroenterol Hepatol; 2003 Mar; 18(3):253-7. PubMed ID: 12603524 [TBL] [Abstract][Full Text] [Related]
31. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. Sumida Y; Nakashima T; Yoh T; Nakajima Y; Ishikawa H; Mitsuyoshi H; Sakamoto Y; Okanoue T; Kashima K; Nakamura H; Yodoi J J Hepatol; 2000 Oct; 33(4):616-22. PubMed ID: 11059866 [TBL] [Abstract][Full Text] [Related]
32. Usefulness of non-invasive serum markers for predicting liver fibrosis in Egyptian patients with chronic HCV infection. El Guesiry D; Moez P; Hossam N; Kassem M Egypt J Immunol; 2011; 18(2):1-12. PubMed ID: 23082465 [TBL] [Abstract][Full Text] [Related]
33. Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis. Nakamura M; Kanda T; Jiang X; Haga Y; Takahashi K; Wu S; Yasui S; Nakamoto S; Yokosuka O PLoS One; 2017; 12(5):e0177302. PubMed ID: 28475652 [TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus infection-associated markers in sera from blood donors in Surabaya, Indonesia. Darmadi S; Soetjipto ; Handajani R; Lusida MI; Soemarto ; Sakugawa H; Ishido S; Hotta H Microbiol Immunol; 1996; 40(5):401-5. PubMed ID: 8805106 [TBL] [Abstract][Full Text] [Related]
35. HIV-positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C. Steininger K; Boyd A; Dupke S; Krznaric I; Carganico A; Munteanu M; Neifer S; Schuetze M; Obermeier M; Arasteh K; Baumgarten A; Ingiliz P J Viral Hepat; 2017 Oct; 24(10):832-839. PubMed ID: 28439936 [TBL] [Abstract][Full Text] [Related]
36. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis. Xie SB; Yao JL; Zheng RQ; Peng XM; Gao ZL Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):69-72. PubMed ID: 14607650 [TBL] [Abstract][Full Text] [Related]
37. Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferase levels. Lai ME; Mazzoleni AP; Farci P; Melis A; Porru A; Orgiana G; Arnone M; Balestrieri A J Med Virol; 1993 Dec; 41(4):282-8. PubMed ID: 7508972 [TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction. Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269 [TBL] [Abstract][Full Text] [Related]
39. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia. Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052 [TBL] [Abstract][Full Text] [Related]
40. [Comparative analysis of hepatitis C virus core protein in the plasma and serum samples from HCV-infected blood donors and patients with hepatitis C]. Masalova OV; Vishnevskaia TV; Shkurko TV; Garanzha TA; Tupoleva TA; Filatov FP; Blokhina NP; Kushch AA Vopr Virusol; 2007; 52(4):11-7. PubMed ID: 17722604 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]